Public-domain · open source
OpenJurist

D.C. Code § 48-841.02

Definitions

Known as the Off-Label Informed Consent Act

The act spans §§ 48–48 (4 sections).

Mar. 26, 2008, D.C

For the purposes of this chapter, the term:

(1) “FDA” means the federal Food and Drug Administration.

(2) “Off-label use” means the use of a prescription drug for human use to treat a condition that is not included in the labeling for that medication, as approved by the federal Food and Drug Administration.

(3) “Prescriber” means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs for human use in the course of a professional practice.

Official source: D.C. Law Library (Council of the District of Columbia). Reproduced from public-domain District of Columbia statutes; confirm against the official source for the current text. Not legal advice.